MEDICAL DEVICE NEWS MAGAZINE

Tuesday, September 27, 2022

MEDICAL DEVICE NEWS MAGAZINE

|

Contact us 561.316.3330

Bridget Ross Appointed New CEO at ChroniSense Medical

“We are pleased Bridget Ross will bring her talents to ChroniSense as CEO,” said Ilan Neugarten, Chairman of the Board of Rainbow Medical, ChroniSense Medical’s largest investor. “We are confident Bridget’s extensive and diverse leadership experience will deliver impactful healthcare solutions to patients and will drive ChroniSense to a leading position in the disease management space.”

Bridget Ross brings more than three decades of strategic, operational and leadership expertise. Prior to joining ChroniSense, she was President of the Global Medical Group at Henry Schein and a member of the company’s Executive Management Committee. There, she led the growth strategy for a $2.4B global medical distribution, solutions and services business, and delivered revenue growth double the industry average.  Before joining Henry Schein,

Bridget Ross served as Vice President, Commercial Operations, Johnson & Johnson (J&J) Medical Device Sector. In this role, she led a commercial operations integration for the ~$12B NA Medical Device business and was instrumental in driving operational efficiencies. Previously, Ms. Ross held multiple executive roles, including Global President at two J&J subsidiaries in the Women’s Health & Urology and Otolaryngology spaces, where she was responsible for the development pipeline and commercialization of multiple innovative products.

“I am delighted to join ChroniSense,” Ms. Bridget Ross said. “The company’s breakthrough technology has the potential to be transformative for patients – a true game-changer in the digital health segment. I’m excited and honored to join the dedicated team at ChroniSense to work toward bringing meaningful benefits to patients, caregivers and shareholders alike.”

“We are excited about the potential for our technology to have an even greater impact on the lives of patients, and we are looking forward to a successful journey with Bridget’s leadership,” said Danny Lange, Founder, President and Director ChroniSense Labs Israel.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.
Subscribe to Medical Device News Magazine

Prodeon Medical Announces Randomization in the Expander-2 Pivotal Clinical Trial Evaluating the Company’s Investigational Treatment for Lower Urinary Tract Symptoms Associated to Benign Prostatic Hyperplasia

The first randomization was performed by Mark Sutton, M.D., F.A.C.S. at Houston Metro Urology in Houston, TX. Dr. Sutton specializes in comprehensive urologic services for men and women including BPH notes Prodeon Medical.

XRHealth Reports Clinical Trial Finds that Virtual Reality Therapy May Serve as Effective Adjunct To Anesthesia For Surgical Procedures

XRHealth notes the findings could lead to a discussion in the medical industry about using non-pharmaceutical interventions during surgical procedures that both enhance the patient experience during surgery and provide a better postoperative recovery.

New Study Suggests REN Comparable to Standard Care Prescribed Medications for Acute Treatment of Chronic Migraines

Prospective data from 78 adult patients with chronic migraines in the U.S. demonstrated effectiveness of REN across four parameters in comparison to standard-care medications.

By using this website you agree to accept Medical Device News Magazine Privacy Policy